News
Latest
-
![]()
Press Releases
-
![Informative content aimed at educating the public about lung cancer, early detection methods, the importance of biomarkers, and general health tips related to cancer prevention and care.]()
Educational Articles
-
![Detailed scientific studies and findings related to lung cancer detection, biomarker research, and other relevant medical research conducted or published by Cizzle Bio or related entities.]()
Research Papers
Cizzle Bio News
Stay informed with the latest updates on Cizzle Bio's milestones, industry news, and significant events. Here, you will find:
-
![Business professionals reviewing company milestones and progress reports in lung cancer diagnostics, highlighting key achievements in medical innovation.]()
Company Milestones
Discover our key achievements and progress in developing cutting-edge lung cancer diagnostics.
-
![Digital collage of news screens showcasing the latest trends and advancements in the biotechnology field, highlighting industry news and updates.]()
Industry News
Keep up with the latest trends and advancements in the biotechnology field.
-
![Doctor and business professional shaking hands, symbolizing strategic partnerships and collaborations to enhance cancer detection efforts.]()
Collaborations and Partnerships
Learn about our strategic partnerships and collaborative efforts to enhance cancer detection.
-
![Doctor presenting at a conference, discussing significant events and advancements in healthcare and biotechnology, highlighting Cizzle Bio's impact.]()
Significant Events
Get insights into important events and conferences that highlight our impact on healthcare and biotechnology.
Cizzle Bio Expands Lung Cancer Test Licensing to the Caribbean
Cizzle Bio, Inc. is expanding its innovative CIZ1B Biomarker Test for early lung cancer detection to the Caribbean, bringing life-saving diagnostics to over 45 million people.
Dr. Warren Kibbe Joins NCI as Deputy Director for Data Science, Ushering in New Era of AI-Driven Cancer Research
NCI’s new Deputy Director for Data Science, Dr. Warren Kibbe, aims to revolutionize cancer research using AI and big data. Learn about his goals and their impact on cancer detection and treatment advancements.
Cizzle Biotechnology Expanding into the USA and Transforming Cancer Screening
In a recent interview, Dr. Allan Syms shares how Cizzle Bio, Inc. is leading the charge in early lung cancer detection in the U.S. with its innovative CIZ1B biomarker test. Find out more about their expansion and clinical collaborations.
Advancing Lung Cancer Detection: Cizzle Biotechnology's Innovative Blood Test
Explore Cizzle Biotechnology's new blood test for early lung cancer detection, featuring the CIZ1B biomarker. Watch the video to learn about the development process and its potential impact.
Cizzle Bio, Inc. is expanding its innovative CIZ1B Biomarker Test for early lung cancer detection to the Caribbean, bringing life-saving diagnostics to over 45 million people.